Hepatitis G virus exposure in dialysis patients

International Urology and Nephrology

Volumn 39, Issue 4, 2007, Pages 1257-1263

  Eslamifar, Ali ^a   Hamkar, Rasool ^b   Ramezani, Amitis ^a   Ahmadi, Farrokhlagha ^b   Gachkar, Latif ^c   Jalilvand, Somayeh ^b   Adibi, Ladan ^b   Atabak, Shahnaz ^c   Khameneh, Ali ^d   Ghadimi, Ramin ^b   Aghakhani, Arezoo ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Anti HGV envelope protein E2; Continuous ambulatory peritoneal dialysis; Haemodialysis; Hepatitis G virus

Indexed keywords

GENOMIC RNA; GLYCOPROTEIN E2; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; NONSTRUCTURAL PROTEIN 5A; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS C; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCREENING TEST; TREATMENT DURATION;

CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HUMANS; IRAN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 36649029724     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-007-9267-x     Document Type: Article

References (58)

1. Simons JN, Leary TP, Dawson GJ et al (1995) Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1:564-569
2. Linnen J, Wages J, Zhang-Keck ZY et al (1996) Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 271:505-508
3. Roth WK, Waschk D, Marx S et al (1997) Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion 37:651-656
4. Katayama K, Kageyama T, Fukushi S et al (1998) Full-length GBV-C/HGV genomes from nine Japanese isolate: Characterization by comparative analyses. Arch Virol 143:1063-1075
5. Li G, Ma HH, Lau GK, Leung YK, Yao CL, Chong YT, Tang WH Yao JL (2002) Prevalence of hepatitis G virus infection and homology of different viral strains in Southern China. World J Gastroenterol 8:1081-1087
6. Lefrère JJ, Roudot TF, Morand JL, Brossard Y et al (1999) Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually-transmitted viruses: Evidence of sexual and parenteral transmission. Transfusion 39:83-94
7. Lefrere JJ, Sender A, Mercier B et al (2000) High rate of GB virus type C/HGV transmission from mother to infant: Possible implications for the prevalence of infection in blood donors. Transfusion 40:602-607
8. Chen M, Sonnerborg A, Johansson B, Sallberg M (1997) Detection of hepatitis G virus (GB virus C) RNA in human saliva. J Clin Microbiol 35:973-975
9. Seemayer CA, Viazov S, Philipp T, Roggendorf M (1998) Detection of GBV-C/ HGV RNA in saliva and serum, but not in urine of infected patients. Infection 26:39-41
10. Yashina TL, Favorov MO, Khudyakov YE et al (1997) Detection of hepatitis G virus (HGV) RNA: Clinical characteristics of acute HGV infection. J Infect Dis 175:1302-1306
11. Ling BH, Zhuang H, Cui YH et al (1998) A cross-sectional study on HGV infection in a rural population. World J Gastroenterol 4:489-492
12. Moaven LD, Locarnini SA, Bowden DS et al (1997) Hepatitis G virus and fulminant hepatic failure: Infection. J Hepatol 27:613-619
13. Sheng L, Soumillion A, Beckers N et al (1998) Hepatitis G virus infection in acute fulminant hepatitis: Prevalence of HGV infection and sequence analysis of a specific viral strain. J Viral Hepatitis 5:301-306
14. Corun C, Jadoul M, Loute G, Goubau P (1997) Hepatitis G virus infection in haemodialysis patients: Epidemiology and clinical relevance. Nephrol Dial Transplant 12:1326-1329
15. Alter HJ, Nakatsuji Y, Melpolder J et al (1997) The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 336:747-757
16. Masuko K, Mitsui T, Iwano K et al (1996) Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 334:1485-1490
17. De Lamballerie X, Charrel RN (1996) Hepatitis GB virus C in patients on hemodialysis. N Engl J Med 334:1549
18. Shibuya A, Takeuchi A, Kamata K et al (1998) Prevalence of hepatitis G virus RNA and anti-E2 in a Japanese haemodialysis population. Nephrol Dial Transplant 13:2033-2036
19. Schulte-Frohlinde E, Schmolke S, Reindl W et al (1998) Significance of antibodies to recombinant E2 protein of hepatitis G virus in haemodialysis patients. J Viral Hepat 5:341-344
20. Campo N, Sinelli N, Brizzolara R et al (1999) Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients. Nephron 82:17-21
21. Hyunjin N, Kang SW, Choi SH et al (1998) Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients. Yonesi Med J 39:116-121
22. Fabrizi F, De Vecchi AF, Lunghi G et al (2002) Epidemiology of GB virus C/Hepatitis G virus infection in patients on peritoneal dialysis. Perit Dial Int 22:405-410
23. Dille BJ, Surowy TK, Gutierrez RA et al (1997) An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 175:458-461
24. Tacke M, Kiyosawa K, Stark K et al (1997) Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 349:318-320
25. Thomas DL, Vlahov D, Alter HJ et al (1998) Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 177:539-542
26. Sugai Y, Nakayama H, Fukuda M et al (1997) Infection with GB virus C in patients with chronic liver disease. J Med Virol 51:175-181
27. Andonov A, Sauder C, Jacobsen H, Chaudhary R (1998) Comparison of six sets of PCR primers from two different genomic regions for amplification of GB virus C/hepatitis G virus RNA J Clin Microbiol 36:286-289
28. Goldblum SE, Reed WP (1980) Host defenses and immunologic alternations associated with chronic hemodialysis. Ann Intern Med 93:597-613
29. Jacobs C, Brunner FP, Chantler C et al (1977) Combined report on regular dialysis and transplantation in Europe, VII, 1976. Proc Eur Dial Transplant Assoc 14:3-69
30. Sheng L, Widyastuti A, Kosala H et al (1998) High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis. Am J Kidney Dis 31:366-368
31. Fabrizi F, Martin P (1999) GBV-C/HGV infection in end-stage renal. J Nephrol 12:131-139
32. Cabrerizo M, Bartolome J, de Sequera P et al (1999) GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells in hemodialysis patients. Kidney Int 56:1120-1128
33. Desassis JF, Laperche S, Girault A et al (1999) Prevalence of present and past hepatitis G virus infection in a French hemodialysis centre. Nephrol Dial Transplant 14:2692-2697
34. Konomi N, Miyoshi C, Zerain CF et al (1999) Epidemiology of hepatitis B, C, E and G virus infection and molecular analysis of hepatitis G isolates in Bolivia. J Clin Microbiol 37:3291-3295
35. Forns X, Fernandez-Llama P, Costa J et al (1997) Hepatitis G virus infection in a haemodialysis unit: Prevalence and clinical implications. Nephrol Dial Transplant 12:956-960
36. Bastani B, Frenche D, Gellens M, Di Bisceglie A (1998) Infection with hepatitis G (HGV) and hepatitis C (HCV) viruses in patients on chronic hemodialysis. Am J Nephrol 9:199A
37. Medina M, Ashby M, Schlüter V et al (1998) Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients. Am J Kid Dis 31:224-226
38. Desai XX, Pal RB, Banker DD (2004) GB virus C/hepatitis G virus infection in Indian blood donors and high-risk groups. Transfus Apher Sci 30:111-117
39. Tsuda F, Hadiwandowo S, Sawada N et al (1996) Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol 49:248-252
40. Zali MR, Mayumi M, Raoufi M, Nowroozi A (1999) GBV-C infection among patients with hepatitis C virus in the Islamic Republic of Iran: A preliminary report. East Mediterr Health J 5:1023-1029
41. Huang JJ, Lee WC, Ruaan MK et al (2001) Incidence, transmission, and clinical significance of hepatitis G virus infection in hemodialysis patients. Eur J Clin Microbiol Infect Dis 20:374-379
42. Pilot-Matias TJ, Carrick RJ, Coleman PF et al (1996) Expression of the GB virus E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 255:282-292
43. Ross RS, Viazov S., Schmitt U et al (1998) Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world (abstr). J Med Virol 54:103-106
44. Szabo A, Viazov S, Heemann U et al (1997) GBVC/HGV infection in renal dialysis and transplant patients. Nephrol Dial Transplant 12:2380-2384
45. Tribl B, Oesterreicher C, Pohanka E et al (1998) GBV-C/HGV in hemodialysis patients: Anti-E2 antibodies and GBV-C/RNA in serum and peripheral blood mononuclear cells. Kidney Int 53:212-216
46. Kallinowski B, Ahmadi R, Seipp S et al (1998) Clinical impact of GB-C virus in haemodialysis patients. Nephrol Dial Transplant 13:93-98
47. Lefrère JJ, Loiseau P, Maury J et al (1997) Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/ hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and Anti-E2 serology Blood 90:3776-3780
48. Stránský J (1996) Discovery of hepatitis G virus. J Czech Physicians 4:99-101
49. Mushahwar IK, Zuckerman JN (1998) Clinical implications of GB virus-C. J Med Virol 56:1-3
50. Hinrichsen H, Leimenstoll G, Stegen G et al (2002) Prevalence of and risk factors for hepatitis G (HGV) infection in haemodialysis patients: a multicentre study. Nephrol Dial Transplant 17:271-275
51. Wang Y, Chen HS, Fan MH et al (1997) Infection with GB virus C and hepatitis C virus in hemodialysis patients and blood donors in Bejing. J Med Virol 52:26-30
52. Tanaka E, Alter HJ, Nakatsuji Y et al (1996) Effect of hepatitis G virus infection on chronic hepatitis C. Ann Int Med 125:740-743
53. Martinot M, Marcellin P, Boyer N et al (1997) Influence of hepatitis G virus infection on the severity of liver disease and response to interferon alpha in patients with chronic hepatitis C. Ann Int Med 126:874-881
54. Fabrizi F, Lunghi G, Bacchini G et al (1997) Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients. Nephrol Dial Transplant 12:1645-1651
55. Tringali G (1998) Prevalence of HGV infection in hemodialysis patients from eastern Sicily, Giorn. Ital Nefrol 15:141-147
56. Filho RR, Carneiro M.AS, Teles SA et al (2004) GB virus C/hepatitis G virus infection in dialysis patients and kidney transplant recipients in central Brazil, Mem Inst Oswaldo Cruz 99:639-643
57. Klusonova H, Pliskova L, Palicka V, Fixa P (2001) Prevalence of viral hepatitis G infection in hemodialysis patients and coinfection with viral hepatitis B and C. Vnitr Lek 47:678-681
58. Lopez-Alcorocho JM, Barril G, Ortiz-Movilla N et al (2001) Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. J Med Virol 63:103-107